RNID launch new market intelligence report on Noise-Induced Hearing Loss

In a new report, launched at the 2009 BIO International Convention in Atlanta, RNID outline how – if developed – a drug to protect hearing before or after excessive noise could be worth $1.9 billion a year to the pharmaceutical and health industries.

Noise-induced hearing loss can be caused by a variety of loud noises from work and leisure, including explosions, loud music and drilling. RNID estimates that 12.6 million people in western countries currently suffer from noise-induced hearing loss. Groups most at risk include military servicemen, construction workers, musicians and people who regularly listen to loud MP3 players.

There are currently no licensed pharmaceuticals available to treat noise-induced hearing loss. However there are very promising lines of research that urgently need to be taken forward. RNID is offering to help pharmaceutical companies interested in exploring these market opportunities. 

Launching the report, RNID’s Executive Director of Science and Enterprise, Dr Mark Downs, said:

“There is an enormous demand for an effective treatment to protect hearing. New drugs and medical interventions could help millions of people worldwide at risk of developing tinnitus and hearing loss from regular loud noise socially and at work.

“RNID can help companies explore opportunities arising from current research into hearing loss and explaining how their technology could be used to protect hearing. Our evidence makes us certain that investment in this area now will lead to huge reward in the future.”

RNID now have five market reports available free of charge, covering the following areas:

Email RNID for the full reports at: research@rnid.org.uk